51. Nonprescription bronchodilator medication use in asthma.
- Author
-
Kuschner WG, Hankinson TC, Wong HH, and Blanc PD
- Subjects
- Adult, Airway Obstruction drug therapy, Airway Obstruction physiopathology, Asthma physiopathology, Attitude to Health, Bronchodilator Agents administration & dosage, Chi-Square Distribution, Confidence Intervals, Drug Prescriptions, Female, Forced Expiratory Volume drug effects, Health Services Accessibility, Humans, Income, Lung drug effects, Lung physiopathology, Male, Nebulizers and Vaporizers, Nonprescription Drugs administration & dosage, Odds Ratio, Patient Education as Topic, Peak Expiratory Flow Rate drug effects, Risk Factors, Self-Assessment, Sex Factors, Surveys and Questionnaires, Sympathomimetics administration & dosage, Sympathomimetics therapeutic use, Vital Capacity drug effects, Asthma drug therapy, Bronchodilator Agents therapeutic use, Nonprescription Drugs therapeutic use, Self Medication
- Abstract
Study Objective: Many persons with asthma self-medicate with widely available and potentially hazardous nonprescription medicines. This study assessed the demographic and clinical covariates of self-treatment with over-the-counter asthma medications (OTCs)., Design and Setting: We conducted an analytical investigation using questionnaires and measures of lung function, comparing OTC and prescription medication users. We recruited adults with asthma by public advertisement., Subjects: We studied 22 exclusive prescription asthma medication users, 15 exclusive OTC users, and 13 other subjects who combined prescription medication use with self-treatment with asthma OTCs. All but one OTC user self-medicated with a nonselective, sympathomimetic metered-dose inhaler., Results: Taking income, access to care, and self-assessed disease severity into account, male gender was strongly associated with exclusive OTC use alone (odds ratio [OR]=8.9, 95% confidence interval [CI]= 1.3 to 61) and mixed OTC-prescription medication use (OR=9.7, 95% CI=1.1 to 83). The covariates of income, access to care, and self-assessed disease severity provided significant additional explanatory power to the model of exclusive OTC use (model chi2 difference 11.3, 5 df, p<0.05). Pulmonary function was similar among OTC and prescription medication users. However, prescription medication users' self-assessed asthma severity (mild compared to more severe) was associated with postbronchodilator reversibility of FEV1 obstruction (6% vs 18% reversibility, p<0.05) while exclusive OTC users' self-assessed severity showed the reverse pattern (19% vs 8%, p=0.2)., Conclusion: Asthma education programs attempting to discourage unregulated bronchodilator use should give consideration to this profile of the "asthmatic-at-risk."
- Published
- 1997
- Full Text
- View/download PDF